AL
ANTH

Airain Ltd’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Airain Ltd’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,853
Closed -$66K – 1201
2015
Q1 		$66K Buy
+1,853
New +$54.8K ﹤0.01% 774

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Airain Ltd's ANTH Position: Q2 2015 in Review

Airain Ltd sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2015, closing a stake of 1,853 shares — an estimated $66K sold.

Airain Ltd first reported a position in ANTH in Q1 2015 and held it in 1 quarter. The position peaked at $66K in Q1 2015. 73 funds tracked by Wall St. Rank hold ANTH as of Q2 2015.

  • Airain Ltd reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Airain Ltd sold 1,853 Anthera Pharmaceuticals, Inc. shares in Q2 2015, an estimated $66K.
  • Airain Ltd first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Airain Ltd's Anthera Pharmaceuticals, Inc. position peaked at $66K in Q1 2015.
  • 73 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2015.

Based on Airain Ltd's 13F filing for Q2 2015, filed 5 Aug 2015.